buildleaf tirzepatide glp-1 BuildLeaf™ GLP-1 Herbal Oral Liquid GobyMeds - Compounded Tirzepatide GLP-1

Kuklina EV, Tong X, George MG, Bansil P

From our small-batch peptide synthesis to our meticulously prepared diluents, every step of our process is designed to deliver that flawless start

doi: 10.1074/jbc.M114.614578 34

For every 10,000 people taking GLP-1 medications for a year, roughly 25 more would experience DVT compared to those not taking the medication

There are no head-to-head outcome data comparing retatrutide with any established agent

Data-dependent MS2 fragmentation for compound identification and annotation was performed via the AquireX workflow (Thermo Scientific), which comprised three deep scans with MS1 resolution at 60,000 and MS2 resolution at 15,000